Write in a clean editor, then format for Extracellular Vesicle in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Extracellular Vesicle is a peer-reviewed journal published by Elsevier, covering Extracellular vesicles in disease, MicroRNA in disease regulation, RNA Interference and Gene Delivery.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Extracellular Vesicle 12 (2023) 45–58.
Formats any DOI in Extracellular Vesicle style. No sign-up. |
| Publishes research in | Extracellular vesicles in disease MicroRNA in disease regulation RNA Interference and Gene Delivery Circular RNAs in diseases Nanoplatforms for cancer theranostics |
| ISSN | 2773-0417 |
| Citation impact (2-yr) | 5.86 |
| h-index | 19 |
| i10-index | 35 |
| Total citations | 1,505 |
| Open access | Yes |
| Top institutions publishing here | Harvard University |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Extracellular vesicles (EVs) are lipid-bilayer delimited membrane structures released by cells, and play a role in intercell communication and disease development. The Global market for EVs in diagnostic and therapeutic applications is expanding. This review maps the current status of EV industry, summarizes the recent advances in EV manufacturing, and focuses on preclinical research involving…
Respiratory diseases are among the leading causes of morbidity and mortality worldwide, coupled with the ongoing coronavirus disease 2019 (COVID-19) pandemic. mRNA lipid nanoparticle (LNP) vaccines have been developed, but their intramuscular delivery limits pulmonary bioavailability. Inhalation of nanoparticle therapeutics offers localized drug delivery that minimizes off targeted adverse effects and has greater patient compliance.…
Exosomes are nanovesicles released from cells due to pathophysiological events. These nanoparticles are resistant to metabolic destruction and can transcend the blood-brain barrier. Exosome therapy could be employed as precision medicine by targeting the underlying etiology. This article briefly elucidates the basic physiology of exosomes, their types, characteristics, and cargo that are employed for drug…
Cardiovascular disease is the leading cause of death worldwide today and numerous studies are demonstrating that exosomes improve cardiac function after myocardial injury through various mechanisms. Exosome therapy has great potential as an effective precision medicine biologic by targeting the underlying disease process. However, this innovative approach may face some challenges, such as zeta potential,…
Extracellular vesicles (EV) as drug delivery nanocarriers are under intense investigation. Although clinical-grade EVs have been produced on a large-scale, low yield and high production costs of natural EVs (nEV) limit the relevant industrial translation. Recent studies show that mechanical extrusion of cells can generate nEV-like cell-derived nanovesicles (CNV) which can also be used as…
